Literature DB >> 12892959

Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study.

Hans Steinsland1, Palle Valentiner-Branth, Håkon K Gjessing, Peter Aaby, Kåre Mølbak, Halvor Sommerfelt.   

Abstract

BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) are an important cause of diarrhoea and diarrhoeal deaths in children living in developing countries and of travellers' diarrhoea. During the past 25 years, vaccine development efforts have been focused on induction of protective immunity against surface colonisation factors (CFs) and the heat-labile enterotoxin. Although vaccines that induce immunity to heat-labile toxin offer protection against diarrhoea from ETEC that produce this toxin, the benefit of including CF antigens remains uncertain. We aimed to estimate the protection that natural ETEC infections induce against new infections.
METHODS: In Guinea-Bissau, we followed up 200 neonates until up to age 2 years, most of whom were breastfed throughout the study. We collected stool specimens from the children every week irrespective of whether they had diarrhoea. As a measure of protection, we used Cox regression models to estimate the change in infection rates after a primary ETEC infection. We thus estimated the protection attributable to CFs, toxins, and to any other factors that could be shared by ETEC with the same toxin-CF profile.
FINDINGS: ETEC infections induced a 47% (95% CI 12 to 69) protection against new infections with ETEC that had the same toxin-CF profile; the corresponding estimate attributable to CFs was -1% (-40 to 27). Infection with heat-labile toxin-positive ETEC conferred a 45% (-1 to 70) protection against symptomatic infections with ETEC positive for this toxin.
INTERPRETATION: For breastfed children living in endemic areas, other antigens are substantially more important than CFs for induction of protective immunity against ETEC infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892959     DOI: 10.1016/S0140-6736(03)13971-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

1.  Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.

Authors:  Koushik Roy; Scott Bartels; Firdausi Qadri; James M Fleckenstein
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Clonal relatedness of enterotoxigenic Escherichia coli strains isolated from a cohort of young children in Guinea-Bissau.

Authors:  Hans Steinsland; Palle Valentiner-Branth; Peter Aaby; Kåre Mølbak; Halvor Sommerfelt
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation.

Authors:  Jason W Sahl; Hans Steinsland; Julia C Redman; Samuel V Angiuoli; James P Nataro; Halvor Sommerfelt; David A Rasko
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

4.  Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development.

Authors:  James M Fleckenstein
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

5.  EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin.

Authors:  Pardeep Kumar; Qingwei Luo; Tim J Vickers; Alaullah Sheikh; Warren G Lewis; James M Fleckenstein
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

6.  Contribution of the highly conserved EaeH surface protein to enterotoxigenic Escherichia coli pathogenesis.

Authors:  Alaullah Sheikh; Qingwei Luo; Koushik Roy; Salwa Shabaan; Pardeep Kumar; Firdausi Qadri; James M Fleckenstein
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

7.  Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.

Authors:  Daisuke Tokuhara; Yoshikazu Yuki; Tomonori Nochi; Toshio Kodama; Mio Mejima; Shiho Kurokawa; Yuko Takahashi; Masanobu Nanno; Ushio Nakanishi; Fumio Takaiwa; Takeshi Honda; Hiroshi Kiyono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 8.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

9.  Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.

Authors:  T S Coster; M K Wolf; E R Hall; F J Cassels; D N Taylor; C T Liu; F C Trespalacios; A DeLorimier; D R Angleberger; C E McQueen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

10.  The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection.

Authors:  Koushik Roy; David Hamilton; Kenneth P Allen; Mildred P Randolph; James M Fleckenstein
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.